Emmeline Cheng

Title: Emmeline Cheng: Innovator in Aptamer Technology

Introduction

Emmeline Cheng is a prominent inventor based in Seattle, WA, known for her groundbreaking work in the field of aptamer technology. With a focus on monocyte and macrophage binding aptamers, her innovations have significant implications for therapeutic applications and drug delivery systems.

Latest Patents

Emmeline Cheng holds a patent titled "Monocyte and macrophage binding aptamers and their application." This patent describes compositions comprising aptamers that specifically bind to monocytes and/or macrophages, along with methods for their use. The aptamer compositions can be utilized for isolating and/or enriching these cell types or depleting populations of monocytes and/or macrophages. Furthermore, the patent outlines methods for employing the aptamers or the cell populations generated using them in therapeutic contexts.

Career Highlights

Cheng has made significant contributions to her field through her work at esteemed institutions such as the University of Washington and Seattle Children's Hospital. Her research has advanced the understanding of cell-targeting technologies, paving the way for innovative therapeutic strategies.

Collaborations

Emmeline Cheng has collaborated with notable colleagues, including Suzie H Pun and Meilyn Sylvestre, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Emmeline Cheng's contributions to aptamer technology exemplify the potential of innovative research in medicine. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.